Search - tctmd.com

Displaying 41 - 60 of 90

Sort: Relevancy | Date

Presentation TVT 2022

Design and Rationale of the CORCINCH-HF Pivotal Study

Presenter: Ulrich Jorde

June 09, 2022

Presentation TVT 2022

12-Month Outcomes for the AccuCinch System in HFrEF

Presenter: Nadira Hamid

June 09, 2022

Presentation TVT 2022

From Access to Anchors: The AccuCinch Ventricular Restoration System

Presenter: Azeem Latib

June 09, 2022

Presentation TVT 2022

Reverse Remodeling in Heart Failure

Presenter: Daniel Burkhoff

June 09, 2022

News Daily News

COVID-19 Vaccination Tied to Better Outcomes in HF Patients

Todd Neale

June 09, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Conference News ESC Heart Failure 2022

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Todd Neale

May 31, 2022

News Conference News ESC Heart Failure 2022

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

Shelley Wood

May 26, 2022

News Conference News ESC Heart Failure 2022

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Shelley Wood

May 25, 2022

News Conference News ESC Heart Failure 2022

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Shelley Wood

May 23, 2022

News Conference News ESC Heart Failure 2022

Dapagliflozin Boosts Health Status Across LVEF Range

Shelley Wood

May 23, 2022

News Conference News ESC Heart Failure 2022

Speech-Recognition Tool May Predict Worsening Congestion in HF

Shelley Wood

May 22, 2022

News Daily News ESC Heart Failure 2022

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

Shelley Wood

May 22, 2022

News Conference News EuroPCR 2022

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

Michael O'Riordan

May 20, 2022

News Conference News EuroPCR 2022

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

Michael O'Riordan

May 19, 2022

News Daily News

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

L.A. McKeown

May 05, 2022

News Daily News

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Caitlin E. Cox

May 03, 2022

News Conference News HRS 2022

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

Todd Neale

May 02, 2022

News Opinion CV Team Dispatch

May 2022 News Roundup

L.A. McKeown

May 01, 2022

News Daily News

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Michael O'Riordan

April 29, 2022

Advertisement

Design and Rationale of the CORCINCH-HF Pivotal Study

12-Month Outcomes for the AccuCinch System in HFrEF

From Access to Anchors: The AccuCinch Ventricular Restoration System

Reverse Remodeling in Heart Failure

COVID-19 Vaccination Tied to Better Outcomes in HF Patients

June 2022 News Roundup

Aficamten Safe, Effective for Up to 6 Months in Obstructive HCM: REDWOOD-HCM OLE

Patch-Pump Delivery of Subcutaneous Furosemide Opens Options in HF

HF Triple Therapy Doesn’t Seem Effective in True Preserved HF

Sweet Spot for Omecamtiv Mecarbil in HFrEF May Lie in Low SBP Patients

Dapagliflozin Boosts Health Status Across LVEF Range

Speech-Recognition Tool May Predict Worsening Congestion in HF

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

MitraClip ‘Bridge’ Strategy Continues to Help Sickest HF Patients

MitraClip Helps for Atrial Functional MR: MITRA-TUNE

DELIVER Trial Scores a Win for Dapagliflozin in HFpEF

Frailty Does Not Hinder Dapagliflozin’s HFrEF Impact: DAPA-HF Analysis

Gains in HF Drug Therapy Raise Questions About ICD Benefit in Modern Era

May 2022 News Roundup

FDA Approves Mavacamten for Obstructive Hypertrophic Cardiomyopathy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content